Extramedullary hematopoiesis in the allograft liver

A. C. Tsamandas, A. B. Jain, R. B. Raikow, A. J. Demetris, M. A. Nalesnik, P. S. Randhawa

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The clinicopathologic correlates of extramedullary hematopoiesis were studied in 77 allograft biopsies from 27 patients who underwent liver transplantation for end-stage liver disease. The patient cohort consisted of 19 men and 8 women, ranging in age from 23 to 75 yr (median 41). The causes of end-stage liver disease included viral hepatitis (n = 20), ethanol abuse (n = 6), and congenital hepatic fibrosis (n = 1). Most patients (23 of 27) had significant septic complications in the postoperative period. The hematocrit was typically low (25 to 31%), and a history of allograft hepatectomy with retransplantation was available in 10 of 27 (37%) patients. Extramedullary hematopoiesis was first diagnosed 5 to 461 days (median 275) post-transplant and persisted 7 days to 36 mo (median 1 mo) thereafter. Pathologic findings concurrent with extramedullary hematopoiesis were acute cellular rejection/central venulitis (n = 7), ischemic preservation injury (n = 10), chronic rejection (n = 5), and chronic hepatitis/cirrhosis (n = 5). The pathogenesis of extramedullary hematopoiesis in these cases is not clear, but a low hematocrit may have been a stimulant for the observed hematopoiesis. In addition, the frequent coexistence of infectious, immunologic, or ischemic injury within the allograft suggests that reparative responses can stimulate intrahepatic stem cells to undergo hematopoietic differentiation. The cytokines likely involved in this process are discussed.

Original languageEnglish (US)
Pages (from-to)671-674
Number of pages4
JournalModern Pathology
Volume8
Issue number6
StatePublished - Jan 1 1995

Fingerprint

Extramedullary Hematopoiesis
Allografts
End Stage Liver Disease
Liver
Hematocrit
Hematopoiesis
Wounds and Injuries
Hepatectomy
Chronic Hepatitis
Postoperative Period
Liver Transplantation
Hepatitis
Fibrosis
Ethanol
Stem Cells
Cytokines
Transplants
Biopsy

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Tsamandas, A. C., Jain, A. B., Raikow, R. B., Demetris, A. J., Nalesnik, M. A., & Randhawa, P. S. (1995). Extramedullary hematopoiesis in the allograft liver. Modern Pathology, 8(6), 671-674.
Tsamandas, A. C. ; Jain, A. B. ; Raikow, R. B. ; Demetris, A. J. ; Nalesnik, M. A. ; Randhawa, P. S. / Extramedullary hematopoiesis in the allograft liver. In: Modern Pathology. 1995 ; Vol. 8, No. 6. pp. 671-674.
@article{c8f7adf53bde4f869a81e80dbe72e293,
title = "Extramedullary hematopoiesis in the allograft liver",
abstract = "The clinicopathologic correlates of extramedullary hematopoiesis were studied in 77 allograft biopsies from 27 patients who underwent liver transplantation for end-stage liver disease. The patient cohort consisted of 19 men and 8 women, ranging in age from 23 to 75 yr (median 41). The causes of end-stage liver disease included viral hepatitis (n = 20), ethanol abuse (n = 6), and congenital hepatic fibrosis (n = 1). Most patients (23 of 27) had significant septic complications in the postoperative period. The hematocrit was typically low (25 to 31{\%}), and a history of allograft hepatectomy with retransplantation was available in 10 of 27 (37{\%}) patients. Extramedullary hematopoiesis was first diagnosed 5 to 461 days (median 275) post-transplant and persisted 7 days to 36 mo (median 1 mo) thereafter. Pathologic findings concurrent with extramedullary hematopoiesis were acute cellular rejection/central venulitis (n = 7), ischemic preservation injury (n = 10), chronic rejection (n = 5), and chronic hepatitis/cirrhosis (n = 5). The pathogenesis of extramedullary hematopoiesis in these cases is not clear, but a low hematocrit may have been a stimulant for the observed hematopoiesis. In addition, the frequent coexistence of infectious, immunologic, or ischemic injury within the allograft suggests that reparative responses can stimulate intrahepatic stem cells to undergo hematopoietic differentiation. The cytokines likely involved in this process are discussed.",
author = "Tsamandas, {A. C.} and Jain, {A. B.} and Raikow, {R. B.} and Demetris, {A. J.} and Nalesnik, {M. A.} and Randhawa, {P. S.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "8",
pages = "671--674",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "6",

}

Tsamandas, AC, Jain, AB, Raikow, RB, Demetris, AJ, Nalesnik, MA & Randhawa, PS 1995, 'Extramedullary hematopoiesis in the allograft liver', Modern Pathology, vol. 8, no. 6, pp. 671-674.

Extramedullary hematopoiesis in the allograft liver. / Tsamandas, A. C.; Jain, A. B.; Raikow, R. B.; Demetris, A. J.; Nalesnik, M. A.; Randhawa, P. S.

In: Modern Pathology, Vol. 8, No. 6, 01.01.1995, p. 671-674.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Extramedullary hematopoiesis in the allograft liver

AU - Tsamandas, A. C.

AU - Jain, A. B.

AU - Raikow, R. B.

AU - Demetris, A. J.

AU - Nalesnik, M. A.

AU - Randhawa, P. S.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The clinicopathologic correlates of extramedullary hematopoiesis were studied in 77 allograft biopsies from 27 patients who underwent liver transplantation for end-stage liver disease. The patient cohort consisted of 19 men and 8 women, ranging in age from 23 to 75 yr (median 41). The causes of end-stage liver disease included viral hepatitis (n = 20), ethanol abuse (n = 6), and congenital hepatic fibrosis (n = 1). Most patients (23 of 27) had significant septic complications in the postoperative period. The hematocrit was typically low (25 to 31%), and a history of allograft hepatectomy with retransplantation was available in 10 of 27 (37%) patients. Extramedullary hematopoiesis was first diagnosed 5 to 461 days (median 275) post-transplant and persisted 7 days to 36 mo (median 1 mo) thereafter. Pathologic findings concurrent with extramedullary hematopoiesis were acute cellular rejection/central venulitis (n = 7), ischemic preservation injury (n = 10), chronic rejection (n = 5), and chronic hepatitis/cirrhosis (n = 5). The pathogenesis of extramedullary hematopoiesis in these cases is not clear, but a low hematocrit may have been a stimulant for the observed hematopoiesis. In addition, the frequent coexistence of infectious, immunologic, or ischemic injury within the allograft suggests that reparative responses can stimulate intrahepatic stem cells to undergo hematopoietic differentiation. The cytokines likely involved in this process are discussed.

AB - The clinicopathologic correlates of extramedullary hematopoiesis were studied in 77 allograft biopsies from 27 patients who underwent liver transplantation for end-stage liver disease. The patient cohort consisted of 19 men and 8 women, ranging in age from 23 to 75 yr (median 41). The causes of end-stage liver disease included viral hepatitis (n = 20), ethanol abuse (n = 6), and congenital hepatic fibrosis (n = 1). Most patients (23 of 27) had significant septic complications in the postoperative period. The hematocrit was typically low (25 to 31%), and a history of allograft hepatectomy with retransplantation was available in 10 of 27 (37%) patients. Extramedullary hematopoiesis was first diagnosed 5 to 461 days (median 275) post-transplant and persisted 7 days to 36 mo (median 1 mo) thereafter. Pathologic findings concurrent with extramedullary hematopoiesis were acute cellular rejection/central venulitis (n = 7), ischemic preservation injury (n = 10), chronic rejection (n = 5), and chronic hepatitis/cirrhosis (n = 5). The pathogenesis of extramedullary hematopoiesis in these cases is not clear, but a low hematocrit may have been a stimulant for the observed hematopoiesis. In addition, the frequent coexistence of infectious, immunologic, or ischemic injury within the allograft suggests that reparative responses can stimulate intrahepatic stem cells to undergo hematopoietic differentiation. The cytokines likely involved in this process are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0029023004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029023004&partnerID=8YFLogxK

M3 - Article

C2 - 8532704

AN - SCOPUS:0029023004

VL - 8

SP - 671

EP - 674

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 6

ER -

Tsamandas AC, Jain AB, Raikow RB, Demetris AJ, Nalesnik MA, Randhawa PS. Extramedullary hematopoiesis in the allograft liver. Modern Pathology. 1995 Jan 1;8(6):671-674.